MicrobiologyJournal of Antimicrobial ChemotherapyPeer-reviewed
A detailed characterisation of drug resistance during darunavir/ritonavir (DRV/r) monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance
Adam Abdullahi, Ana García-Díaz, Olga Mafotsing Fopoussi…·Anna María Geretti
This study characterizes drug resistance during DRV/r monotherapy, finding no DRV resistance mutations but identifying alternative resistance pathways through gag substitutions.
7 citations